Tag: clinical study
Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials
Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.
Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut Therapy
First of 440 patients enrolled in study of AR101.
Epinephrine First, Period
The AAP dispels common misconceptions about when to use the drug with anaphylaxis.
NIH Designates $42 Million to Food Allergy Research Group over 7 Years
CoFAR has done important clinical research since 2005 and will continue with NIH funding.
Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of 2017
The study received higher-than-expected patient demand.
Must Read: Allergic Living’s 2017 AAAAI Meeting Summary
Research highlights from the AAAAI annual meeting held in Atlanta a few weeks ago.
Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials
Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.
Viaskin Peanut Patch: Lasting Response After Three Years
Pediatric patients responded with a favorable safety profile and no serious adverse effects.
Food Allergy Immunotherapy Advances Presented at AAAAI Meeting
Here's a quick recap from this morning's AAAAI press release.
Positive Results Announced for Peanut Allergy Vaccine
Another food allergy therapy showing early promise.
